A+ | A | A- | Skip to main content |

Sensex

Nifty

USDINR

GBPINR

EURINR

Thursday, 25 June 2026 12:00 AM EOD	Asian-Paints2645.85	Hind-Unilever2173.25	ITC290.05	Trent3217.25	Larsen-and-Toubro4219.95	M-and-M3181.80	Reliance-Industries1318.25	Tata-Steel188.70	Titan-Company4289.65	SBI1045.15	Bharat-Electron406.80	Kotak-Mah-Bank409.00	Infosys1041.40	Bajaj-Finance979.90	Sun-PharmaInds1862.15	HDFC-Bank796.05	TCS2095.60	ICICI-Bank1387.90	Power-Grid-Corpn283.95	Maruti-Suzuki13741.75	Axis-Bank1376.55	HCL-Technologies1101.45	NTPC352.15	Bharti-Airtel1850.15	Tech-Mahindra1436.65	Adani-Ports1796.25	UltraTech-Cem11493.30	Bajaj-Finserv1764.15	Interglobe-Aviat5449.65	Eternal255.25
15 mins delay SENSEX 77,100.47 [109.25]	-21.30 -0.80%	15.45 0.72%	-0.20 -0.07%	-29.10 -0.90%	37.75 0.90%	117.20 3.82%	4.55 0.35%	-1.45 -0.76%	-40.80 -0.94%	10.50 1.01%	-6.95 -1.68%	3.00 0.74%	-15.05 -1.42%	-10.90 -1.10%	-12.55 -0.67%	2.90 0.37%	-13.15 -0.62%	13.90 1.01%	-6.85 -2.36%	489.65 3.69%	-7.55 -0.55%	-11.90 -1.07%	-4.85 -1.36%	-26.85 -1.43%	-24.60 -1.68%	-17.05 -0.94%	54.85 0.48%	-16.35 -0.92%	246.15 4.73%	-1.05 -0.41%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aurobindo Pharma's API unit clears USFDA inspection with two observations

27-Jun-26 15:21Hrs IST

The inspection, conducted between 22 June and 26 June 2026, covered the facility that manufactures active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates.

The inspection concluded with two observations. The company said it will respond to the observations within the stipulated timeline.

Aurobindo Pharma reiterated its commitment to maintaining the highest quality manufacturing standards and said it will keep the stock exchanges informed of any further developments related to the inspection.

Aurobindo Pharma is engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services. The company reported a 2% rise in consolidated net profit to Rs 921.26 crore on a 4.4% increase in net sales to Rs 8,751.50 crore in Q4 FY26 over Q4 FY25.

The counter advanced 1.65% to end at Rs 1,554.95 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise